Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Century Therapeutics, Inc.
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
September 26, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 08, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
June 03, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
May 10, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 09, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 23, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
April 11, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
April 08, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 19, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
March 14, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
March 05, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
December 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
December 06, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus
December 06, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases
November 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer
November 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits at the 65th ASH Annual Meeting and Exposition
November 02, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference
September 26, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 09, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
May 11, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
April 17, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces Leadership Changes
April 12, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates
March 16, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at the AACR Annual Meeting 2023
March 15, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Upcoming Investor Conferences
February 21, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas
February 08, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Century Therapeutics to Present at Upcoming Investor Conferences
February 01, 2023
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.